Want to join the conversation?
For 2Q16, $CHS recorded pre-tax restructuring and strategic charges of $16.6MM, mainly consisting of severance, proxy solicitation costs, and consulting fees. On an after-tax basis, 2Q impact of these charges was $10.3MM, or $0.08 per diluted share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?